Literature DB >> 26429217

Disseminated Mycobacterium haemophilum skeletal disease in a patient with interferon-gamma deficiency.

O Otome1, M O'Reilly1, L Lim1.   

Abstract

Disseminated non-tuberculous mycobacterial (NTM) infection is rare in immunocompetent adults. Anti-interferon-gamma (IFN-γ) autoantibodies have recently been associated with NTM infections, particularly in patients of Asian ethnicity. We describe a case of disseminated Mycobacterium haemophilum skeletal infection due to anti IFN-γ autoantibodies in a 71-year-old Cambodian man. He responded to a combination of anti-mycobacterial antibiotics without requirement for immunomodulator therapy. Testing for acquired IFN-γ deficiency due to IFN-γ autoantibodies should be considered when standard tests for immunodeficiency are negative in patients with unusual or severe opportunistic infections, including NTM.
© 2015 Royal Australasian College of Physicians.

Entities:  

Keywords:  Asian; IFN-gamma; Mycobacterium; immunodeficiency

Mesh:

Substances:

Year:  2015        PMID: 26429217     DOI: 10.1111/imj.12875

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  5 in total

Review 1.  [Nontuberculous mycobacterial infections].

Authors:  A Nowag; M Platten; G Plum; P Hartmann
Journal:  Z Rheumatol       Date:  2017-11       Impact factor: 1.372

Review 2.  Host Immune Response and Novel Diagnostic Approach to NTM Infections.

Authors:  Yuko Abe; Kiyoharu Fukushima; Yuki Hosono; Yuki Matsumoto; Daisuke Motooka; Naoko Ose; Shota Nakamura; Seigo Kitada; Hiroshi Kida; Atsushi Kumanogoh
Journal:  Int J Mol Sci       Date:  2020-06-18       Impact factor: 5.923

Review 3.  Anti-Interferon Autoantibodies in Adult-Onset Immunodeficiency Syndrome and Severe COVID-19 Infection.

Authors:  Long-Fang Chen; Cheng-De Yang; Xiao-Bing Cheng
Journal:  Front Immunol       Date:  2021-12-22       Impact factor: 7.561

Review 4.  '"Why me, why now?" Using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infection.

Authors:  M Alexandra Lake; Lyn R Ambrose; Marc C I Lipman; David M Lowe
Journal:  BMC Med       Date:  2016-03-23       Impact factor: 8.775

5.  Clinical Characteristics and Treatment Outcomes for Patients Infected with Mycobacterium haemophilum.

Authors:  Pornboonya Nookeu; Nasikarn Angkasekwinai; Suporn Foongladda; Pakpoom Phoompoung
Journal:  Emerg Infect Dis       Date:  2019-09       Impact factor: 6.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.